Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 09.06.2012

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
09.06.12Kia Racing's No. 12 Infinity Audio Forte Koup Claims Second-Place at Mid-Ohio Sports Car Course277LEXINGTON, Ohio, June 9, 2012 /PRNewswire/ --Round five of the 2012 Continental Tire Sports Car Challenge (CTSCC) at the Mid-Ohio Sports Car Course was an historic...
► Artikel lesen
09.06.12Pennsylvania DCED Secretary Walker and DEP Secretary Krancer Release Statement on Inaccurate Reports on Horsehead Site Remediation239HARRISBURG, Pa., June 9, 2012 /PRNewswire-USNewswire/ --Department of Environmental Protection Secretary Michael Krancer and Department of Community and Economic Development Secretary...
► Artikel lesen
09.06.12Pre-Father's Day Event: Dallas Cowboys' Jason Witten and FRAM Team Up to Teach Car Care Skills to Dads and Their Kids, Boys & Girls Clubs of Greater Dallas264LAKE FOREST, Ill., June 9, 2012 /PRNewswire/ -- The Car Care Council's top tip to parents of teen drivers: Ensure that your young drivers know basic preventive maintenance to keep them safe on the...
► Artikel lesen
09.06.12School Bus Drivers, Teamsters Rally At Napa Valley Vineyard84School Bus Drivers, Teamsters Rally At Napa Valley Vineyard Teamsters Call on Benessere Vineyards Owner and Cook-Illinois CEO to Stop Squashing School Bus Workers' Rights SAN FRANCISCO,...
► Artikel lesen
09.06.12Post-hoc analysis of linagliptin phase 3 data in adults with type 2 diabetes and albuminuria presented264RIDGEFIELD, Conn. and INDIANAPOLIS, June 9, 2012 /PRNewswire/ --Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from a post-hoc analysis, which...
► Artikel lesen
09.06.12Utility Workers File Unfair Labor Practice Against Entergy for "Coercive, Threatening Statements" and Video and Audio Taping Workers Outside Pilgrim Nuclear116UWUA Local 369 files complaint with National Labor Relations Board that includes five charges against Entergy following lockout of experienced workers at Pilgrim Nuclear Power Plant BRAINTREE...
► Artikel lesen
09.06.12Serono Symposia International Foundation Award 201270PRAGUE, June 9, 2012 /PRNewswire/ -- Serono Symposia International Foundation (SSIF), has announced today during the ENS(European Neurological Society)Congress, which is being held in Prague from...
► Artikel lesen
09.06.12Lyxumia (lixisenatide) in Combination with Basal Insulin plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose83PARIS, France, June 9, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today data demonstrating Lyxumia®* (lixisenatide), a once-daily investigational...
► Artikel lesen
09.06.12Cebix's Once-Weekly Ersatta' for Diabetic Peripheral Neuropathy Well Tolerated in Clinical Study82PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Cebix Incorporated today announced that data from a Phase 1 study demonstrated that Ersatta', the company's long-acting form of C-peptide, was well tolerated...
► Artikel lesen
09.06.12Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies75PHILADELPHIA, June 9, 2012 /PRNewswire/ --Janssen Research & Development, LLC (Janssen) presented results from five Phase 3 clinical studies evaluating canagliflozin in monotherapy and in add-on combination...
► Artikel lesen
09.06.12Interim Data From Pre-administration of Hylenex in Analog Insulin Pump Therapy Demonstrate Consistent Insulin Action Profile: Data Presented in Late-Breaker Poster at ADA 2012150PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today presented results from a Phase 4 study of Hylenex® recombinant (hyaluronidase human injection) in sensor...
► Artikel lesen
09.06.12Halozyme Presents Positive Data from Two Ultrafast Insulin Clinical Trials with Human Hyaluronidase Enzyme - rHuPH20 - at ADA 201296PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of two posters at the 72nd Scientific Sessions of the American Diabetes Association...
► Artikel lesen
09.06.1290-week data suggest sustained glucose reduction and weight loss with investigational SGLT-2 inhibitor, empagliflozin62RIDGEFIELD, Conn. and INDIANAPOLIS, June 9, 2012 /PRNewswire/--Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) presented results that showed empagliflozin (BI 10773)...
► Artikel lesen
09.06.12Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company present new linagliptin data at American Diabetes Association's 72nd Scientific Sessions198RIDGEFIELD, Conn. and INDIANAPOLIS, June 9, 2012 /PRNewswire/ --Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) presented results from two randomized phase 3 clinical...
► Artikel lesen
09.06.12Metabolic Solutions Development Company novel insulin sensitizer meets Phase 2b study endpoints and affirms new mechanism of action66PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) presented Phase 2b results for MSDC-0160 today at the 72nd Scientific Sessions of the American Diabetes...
► Artikel lesen
09.06.12Metabolic Solutions Development Company Identifies New Drug Target for Treatment of Type 2 Diabetes81PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which anti-diabetic drugs exert...
► Artikel lesen
09.06.12Lantus Initiation after Metformin Achieved Superior Glycemic Control versus Sitagliptin in Type 2 Diabetes68PARIS, France, June 9, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SANand NYSE: SNY) announced today that people with early type 2 diabetes uncontrolled on metformin demonstrated superior HbA1c - glycated...
► Artikel lesen
09.06.12Report: Miami-Dade Animal Services to Hold Very Special Adoption Events in Participation of National No-Kill Event: "Just One Day"70 MIAMI-DADE, Fla., June 9, 2012 /PRNewswire-USNewswire/ -- Miami-Dade Animal Services will be holding very special adoption events on Sunday, June 10, and Monday, June 11, 2012, joining animal shelters...
► Artikel lesen
09.06.12American Oriental Bioengineering Announces Boke Subsidiary Passes Inspection111NEWARK, N.J., June 9, 2012 /PRNewswire-Asia-FirstCall/ --American Oriental Bioengineering, Inc., (the "Company" or "AOBI"), a pharmaceutical company dedicated to improving health through the development...
► Artikel lesen
09.06.12Evergrande Continued to Rank No.1 Among the TOP 10 Mainland Real Estate Enterprises Listed in Hong Kong140BEIJING, June 9, 2012 /PRNewswire-Asia/ --On June 9, "China Real Estate TOP 10 Research Group" released the Research Report on the 2012 Chinese TOP 10 Listed Real Estate Enterprises in Beijing, which...
► Artikel lesen
Seite:  Weiter >>